<?xml version="1.0" encoding="UTF-8"?>
<p>The oral consumption of mistletoe lectins as an alternative therapy towards cancer therapy has been advocated by some parties as these lectins are resistant towards low pH in the stomach and are not affected by proteolytic enzymes in the stomach [
 <xref ref-type="bibr" rid="CR56">56</xref>]. Pryme et al. (2007) provide a meticulous case report with more information on this topic [
 <xref ref-type="bibr" rid="CR56">56</xref>]. However, the usefulness of mistletoe extracts in the treatment of malignant melanoma is still controversial for some. This may be in part due to the fact that the full molecular mechanisms underlying mistletoe treatment and how it works 
 <italic>in vivo</italic> are still not completely clarified.
</p>
